Dec 8
|
Rigel Pharmaceuticals and MD Anderson Announce Strategic Alliance to Advance REZLIDHIA® (Olutasidenib) in AML and Other Cancers
|
Aug 30
|
Rigel to Participate in Upcoming September Investor Conferences
|
Apr 26
|
Earnings Preview: Pacira (PCRX) Q1 Earnings Expected to Decline
|
Apr 25
|
Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
|
Apr 25
|
Rigel Announces Conference Call and Webcast to Report First Quarter 2023 Financial Results and Business Update
|